The LMC Diabetes and Endocrinology clinics provide a practice home to the world’s largest group of clinical endocrinologists, in thirteen clinics across nine Canadian cities, within three Canadian provinces. Each site is a regional centre of excellence providing multidisciplinary diabetes care for people with type 1 and type 2 diabetes, within the Canadian public health system. All sites use a common electronic medical record system, aligned to Diabetes Canada Clinical Practice Guidelines. All providers follow a consistent and structured approach to diabetes care, based on the clinical practice guidelines.
The LMC Diabetes Registry houses all the medical and demographic information of the cohort under care, including medications, lab results, hypoglycemia, device usage, and glucose monitoring data (Glooko/Clarity/LibreView/Carelink). Registry data analysis occurs only through patient consent (current consent participation rate is ~92%).
The LMC Diabetes Registry has provided foundational insights into the impact of new therapies, educational interventions and devices in the glycemia and outcomes of a large Canadian population with diabetes. Over the past decade, more than fifty major publications and presentations have resulted from analyses of the Registry. Future directions will include insights into the lower limb health of healthy individuals with diabetes, the prevalence and natural history of non-alcoholic fatty liver disease among the type 2 diabetes population, and the course of diabetic kidney disease in Canadians living with diabetes.
ALL ACTIVE PATIENTS
Type 1 Diabetes (n=4,212)
Type 2 Diabetes (n=38,216)
Chronic Kidney Disease in Type 1 Diabetes
Chronic Kidney Disease in Type 2 Diabetes
- eGFR ≤60 12.8% 12.8%
- uACR ≥2.0 22.2% 22.2%
- Both eGFR ≤60 and uACR ≥2.0 5.8% 5.8%
- Either eGFR ≤60 OR uACR ≥2.0 29.1% 29.1%
- eGFR ≤60 24.8% 24.8%
- uACR ≥2.0 40% 40%
- Both eGFR ≤60 and uACR ≥2.0 15.1% 15.1%
- Either eGFR ≤60 OR uACR ≥2.0 49.6% 49.6%